Search Results
FOCUS AREA
Health
Pursuing research, policy analysis, and program evaluation in the quest to improve all aspects of human health
SOLUTION
Analytical Chemistry and Pharmaceutics
Offering method development and validation, formulation, and characterization in support of client needs and research applications
Showing results 1 to 20 of 22.
News Release
FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
August 14, 2019
RTI In The Media
Doris Rouse's Lifelong Journey to Save Those Suffering from Tuberculosis
November 08, 2019 - Triangle Business Journal
RTI In The Media
Cannabis Doesn’t Enhance Performance. So Why Is It Banned in Elite Sports?
November 09, 2021 - PBS
RTI In The Media
FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB
August 15, 2019 - Medscape
Expert
Archana Krovi
News Release
NCCU and RTI celebrate new partnership and shared lab space supporting health and environmental justice research
May 04, 2022
RTI In The Media
RTP-Based APIE Therapeutics, RTI Team Up to Develop Drug for Rare Lung Disease
August 26, 2020 - WRAL TechWire
News Release
RTI International Licenses Portfolio of Compounds to APIE Therapeutics
August 25, 2020
RTI In The Media
‘More Power in Knowing’: PFAS Health Study Under Way in Montgomery, Bucks Counties
December 14, 2021 - WHYY
Expert
Sara Maloney Norcross
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 14, 2019 - The Telegraph
RTI In The Media
Breakthrough in Fight Against Multi-Resistant Tuberculosis
September 02, 2019 - Forbes
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 15, 2019 - Yahoo News UK
RTI In The Media
Landmark Study Highlights Promising PTSD Treatment
January 21, 2020 - WUNC
Impact
Senna Side Effects: Measuring Chemicals in a Botanical Dietary Supplement
June 08, 2021
RTI In The Media
Ep 41: Bruce Blough, Elliott Pauli & CC4CARB
September 05, 2022 - The AMR Studio Podcast
RTI In The Media
After 20 Years of Research, RTI Drug Approved for Drug-Resistant Tuberculosis
August 14, 2019 - Triangle Business Journal
Announcement
New Paper Describes Accurate, Scalable Method for Detecting Fragile X Syndrome in Newborns
March 05, 2020
RTI In The Media
How K2 and Other Synthetic Cannabinoids Got Their Start
November 28, 2018 - The Scientist
Announcement
RTI Secures Chemistry Center for Combating Antibiotic Resistance (CC4CARB) Contract from National Institute of Allergy and Infectious Diseases to Address Bottlenecks in Early Antibiotic Drug Discovery
April 16, 2021